Humana Inc (HUM · NYSE)

HUM · MARKET VIEW

Market view · as of Jul 20, 2026

Revenue (TTM)
$137.20B
+23.5% YoY
Gross margin
14.0%
EPS (latest q)
$10.31
vs $10.20 est · beat
52-wk position
96.2%
-2.3% vs 52w high · +10.8% 1mo

Price (last ~year)

Humana Inc. (HUM) shares are trading at $400.00, reflecting an 84.5% gain over the last three months despite a 4.6% year-over-year decline in earnings. The company reported $1.19 billion in net income for the quarter ending March 31, 2026, marking a recovery from the $796 million net loss in the prior quarter, on trailing twelve-month revenue of $137.20 billion. With a market capitalization of $48.02 billion and a P/E ratio of 42.73, the stock currently trades above the analyst price target of $346.71, while carrying $13.99 billion in total debt and a debt-to-EBITDA ratio of 4.2x.

Valuation

Market cap
$48.02B
P/E
42.73
PEG
2.266
P/B
2.585
P/S
0.35
Beta
0.717
Analyst target
$346.71

Quality & returns

Gross margin
14.0%
Operating margin
4.7%
Profit margin
0.8%
ROE
6.3%
ROA
3.6%

Price movement

Last
$400.00
1-month
+10.8%
3-month
+84.5%
RSI (14)
58
vs SMA200
+54.8%
52-wk position
96.2% -2.3% vs high

Quarterly trajectory

Revenue by quarter (oldest → newest)

QuarterRevenueOp incomeNet incomeEBITDA
2026-03-31$39.65B$1.58B$1.19B$1.97B
2025-12-31$32.52B$-1.02B$-796.0M$-685.0M
2025-09-30$32.65B$108.0M$195.0M$480.0M
2025-06-30$32.39B$722.0M$545.0M$1.09B

Recent news

Sources this view read

  • fundamentals Company overview & valuation (Alpha Vantage OVERVIEW)
  • filing Quarterly financial statements (Alpha Vantage INCOME/BALANCE/CASH)
  • earnings Reported earnings history (Alpha Vantage EARNINGS)
  • prices Adjusted daily prices (Alpha Vantage TIME_SERIES_DAILY_ADJUSTED)

Other snapshots